Nebenwirkungen · Zubsolv
Zubsolv 0.7 mg/0.18 mg sublingual tablets Zubsolv 1.4 mg/0.36 mg sublingual tablets Zubsolv 2.9 mg/0.71 mg sublingual tablets Zubsolv 5.7 mg/1.4 mg sublingual tablets Zubsolv 8.6 mg/2.1 mg sublingual tablets Zubsolv 11.4 mg/2.9 mg sublingual tablets · Abschnitt 4.8 · PDF-Seite 11–13
HOS-138589 · Präparat HOS-098216
System Organ Very Common Uncommon Not known Class common Infections and Influenza Urinary tract infestations Infection infection Pharyngitis Vaginal infection Rhinitis Blood and Anaemia lymphatic Leukocytosis system Leukopenia disorders Lymphadenopathy Thrombocytopenia Immune system Hypersensitivity Anaphylactic disorders shock Metabolism and Decreased appetite nutrition Hyperglycaemia disorders Hyperlipidaemia Hypoglycaemia Psychiatric Insomnia Anxiety Abnormal dreams Hallucination disorders Depression Agitation Libido Apathy decreased Depersonalisation Nervousness Drug dependence Thinking Euphoric mood abnormal Hostility Nervous system Headache Migraine Amnesia Hepatic disorders Dizziness Hyperkinesia encephalopathy Hypertonia Seizure Syncope 11 System Organ Very Common Uncommon Not known Class common Paraesthesia Speech disorder Somnolence Tremor Eye disorders Amblyopia Conjunctivitis Miosis Lacrimal disorder Ear and Vertigo labyrinth disorders Cardiac Angina pectoris disorders Bradycardia Myocardial infarction Palpitations Tachycardia Vascular Hypertension Hypotension Orthostatic disorders Vasodilatation hypotension Respiratory, Cough Asthma Dyspnoea Bronchospasm thoracic and Yawning Respiratory mediastinal depression disorders Gastrointestinal Constipation Abdominal Mouth ulceration Dental caries disorders Nausea pain Diarrhoea Tongue Dyspepsia discolouration Flatulence Vomiting Hepatobiliary Hepatitis disorders Hepatitis acute Jaundice Hepatic necrosis Hepatorenal syndrome Skin and Hyperhidrosis Pruritus Rash Acne Alopecia Angioedema subcutaneous Urticaria Dermatitis exfoliative tissue disorders Dry skin Skin mass Musculoskeletal Back pain Arthritis and connective Arthralgia tissue disorders Muscle spasms Myalgia Renal and Urine Albuminuria urinary abnormality Dysuria disorders Haematuria Nephrolithiasis Urinary retention Reproductive Erectile Amenorrhoea system and dysfunction Ejaculation breast disorders disorder Menorrhagia Metrorrhagia General Drug Asthenia Hypothermia Drug disorders and withdrawal Chest pain withdrawal administration syndrome Chills syndrome site conditions Pyrexia neonatal Malaise pain 12 System Organ Very Common Uncommon Not known Class common Oedema peripheral Investigations Liver function Blood creatinine Transaminases test abnormal increased increased Weight decreased Injury, Injury Heat stroke poisoning and procedural complications
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-08T09:49:00Z · SHA-256 5abf2fbb0a7fd36ed1be04f576c9d6b4a021a25a707c692fa21b326376a4f2b5 · Passage d3c0a534c66ac0b1700a06df8b999e74e4a2bb1ed4ca41ff57b6d86d3cbcfd87 · Zeichen 1046–7688 im Abschnitt